New You Stock Return On Asset
| NWYUDelisted Stock | USD 0.0003 0.00 0.00% |
New You fundamentals help investors to digest information that contributes to New You's financial success or failures. It also enables traders to predict the movement of New OTC Stock. The fundamental analysis module provides a way to measure New You's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to New You otc stock.
New |
New You OTC Stock Return On Asset Analysis
New You's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current New You Return On Asset | -2.64 |
Most of New You's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, New You is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, New You has a Return On Asset of -2.6424. This is 69.8% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is notably higher than that of the company.
New Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses New You's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of New You could also be used in its relative valuation, which is a method of valuing New You by comparing valuation metrics of similar companies.New You is currently under evaluation in return on asset category among its peers.
New Fundamentals
| Return On Asset | -2.64 | |||
| Operating Margin | (2.67) % | |||
| Current Valuation | 1.46 M | |||
| Shares Outstanding | 49.95 M | |||
| Shares Owned By Insiders | 52.02 % | |||
| Price To Sales | 0.01 X | |||
| Revenue | 2.01 M | |||
| Gross Profit | 1.72 M | |||
| EBITDA | (4.24 M) | |||
| Net Income | (5.05 M) | |||
| Cash And Equivalents | 14.58 K | |||
| Total Debt | 128.88 K | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.24) X | |||
| Cash Flow From Operations | (486.37 K) | |||
| Earnings Per Share | (0.34) X | |||
| Beta | -8.46 | |||
| Market Capitalization | 14.99 K | |||
| Total Asset | 197.09 K | |||
| Z Score | -59.31 | |||
| Net Asset | 197.09 K |
About New You Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze New You's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of New You using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of New You based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in New OTC Stock
If you are still planning to invest in New You check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the New You's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |